Ongentys

Pandemic Delays Neurocrine’s Drug Launch for Parkinson’s Disease
BioSpace
Sat, 05/16/20 - 11:49 am
Neurocrine
drug launches
Ongentys
Parkinson's Disease
pandemic
COVID-19
FDA Approves Neurocrine Biosciences' Parkinson's Drug
Motley Fool
Mon, 04/27/20 - 07:35 pm
Neurocrine
FDA
Ongentys
Parkinson's Disease
Neurocrine adds a Parkinson’s drug to its late-stage pipeline in $145M deal
Endpoints
Thu, 02/9/17 - 09:24 pm
Neurocrine
Parkinson's Disease
Ongentys
Bial